Down-Regulation of A-Fabp Predicts Non-Muscle Invasive Bladder Cancer Progression: Investigation With a Long Term Clinical Follow-Up

BMC Cancer - United Kingdom
doi 10.1186/s12885-018-5137-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Assessment of Recurrence and Progression Risk in Patients With Non-Muscle Invasive Bladder Cancer

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2016English

Long Non-Coding RNAs Identify a Subset of Luminal Muscle-Invasive Bladder Cancer Patients With Favorable Prognosis

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2019English

RRM1 Predicts Clinical Outcome of High-And Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Patients Treated With Intravesical Gemcitabine Monotherapy

BMC Urology
MedicineReproductive MedicineUrology
2019English

Long-Term Outcomes From Re-Resection for High-Risk Non–muscle-Invasive Bladder Cancer: A Potential to Rationalize Use

European Urology Focus
Urology
2019English

Mutational Landscape of Non-Muscle-Invasive Bladder Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2018English

Dietary Patterns and Risk of Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Long Term Follow-Up of Ileocystoplasty for Tuberculous Contracted Bladder

Japanese Journal of Urology
Urology
1982English

Long-Term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-Invasive Bladder Cancer Refractory to Standard Intravesical Therapy

Urology
Urology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy